The prognostic value of serum immunosuppressive effect in patients with ovarian cancer. 1979

K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa

Sixteen patients who underwent surgery and postoperative chemotherapy for carcinoma of the ovary were studied. Eleven survived more than 18 months without evidence of recurrence, and 5 died more than 5 months after surgery. Serial determinations were made preoperatively and postoperatively of the immunosuppressive effect of the serums of these patients on the response of normal lymphocytes to phytohemagglutinin stimulation. These determinations were plotted for each patient; the shapes of the curves for patients who survived are markedly different from those of patients who died. The prognostic value of these findings is discussed.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
September 2018, Anticancer research,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
June 2018, Clinical chemistry and laboratory medicine,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
January 2020, American journal of translational research,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
February 2019, Oncology letters,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
January 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
January 2019, Journal of Cancer,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
January 1985, Journal of cancer research and clinical oncology,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
March 1989, Irish journal of medical science,
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
January 2015, Wiadomosci lekarskie (Warsaw, Poland : 1960),
K Ueda, and M Toyokawa, and H Nakamori, and H Sako, and N Umesaki, and J Nakade, and T Lee, and T Sugawa
October 2014, Croatian medical journal,
Copied contents to your clipboard!